Literature DB >> 1748956

Assessing psychotropic medication side effects among children. A reliability study.

C A Garvey, D Gross, L Freeman.   

Abstract

The Dosage Record Treatment Emergent Symptom Scale (DOTES) is a rating scale for measuring the presence and intensity of psychotropic medication side effects. Studies to evaluate its reliability have not been published. The purposes of this pilot study are to (1) develop a protocol for training raters to use the DOTES, (2) assess inter-rater agreement, 3) examine the reasons for disagreement among raters to clarify training procedures and symptom definitions, and (4) further refine this instrument for use in clinical and research settings. Five nurses were trained to use the DOTES to rate the absence or presence and intensity of specific medication side effects. After training, Raters 1, 2, and 3 watched a videotape of a nurse interviewing a 13-year-old child and completed the DOTES rating scale. There was agreement on the intensities of 6 (67%) of the 9 symptoms identified as present and agreement on 17 (89%) of the 19 symptoms identified as absent. Process tracings were conducted on the ratings of Nurses 4 and 5 to elicit the criteria they used to determine their ratings. The results of the process tracings were used to identify ambiguities that led to disagreement among raters so that the training protocol and interview could be improved.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748956     DOI: 10.1111/j.1744-6171.1991.tb00509.x

Source DB:  PubMed          Journal:  J Child Adolesc Psychiatr Ment Health Nurs        ISSN: 0897-9685


  5 in total

1.  Brain circuitry, behavior, and cognition: A randomized placebo-controlled trial of donepezil in fragile X syndrome.

Authors:  Jennifer L Bruno; Sm Hadi Hosseini; Amy A Lightbody; Mai K Manchanda; Allan L Reiss
Journal:  J Psychopharmacol       Date:  2019-07-02       Impact factor: 4.153

2.  A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome.

Authors:  Siddharth Srivastava; Booil Jo; Bo Zhang; Thomas Frazier; Anne Snow Gallagher; Fleming Peck; April R Levin; Sangeeta Mondal; Zetan Li; Rajna Filip-Dhima; Gregory Geisel; Kira A Dies; Amelia Diplock; Charis Eng; Rabi Hanna; Mustafa Sahin; Antonio Hardan
Journal:  Hum Mol Genet       Date:  2022-10-10       Impact factor: 5.121

3.  A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.

Authors:  Karen J Parker; Ozge Oztan; Robin A Libove; Noreen Mohsin; Debra S Karhson; Raena D Sumiyoshi; Jacqueline E Summers; Kyle E Hinman; Kara S Motonaga; Jennifer M Phillips; Dean S Carson; Lawrence K Fung; Joseph P Garner; Antonio Y Hardan
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

4.  Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.

Authors:  Diego Primavera; Mirko Manchia; Luca Deriu; Massimo Tusconi; Roberto Collu; Maria Scherma; Paola Fadda; Walter Fratta; Bernardo Carpiniello
Journal:  BMJ Open       Date:  2017-05-25       Impact factor: 2.692

5.  A randomized double-blind controlled trial of everolimus in individuals with PTEN mutations: Study design and statistical considerations.

Authors:  Antonio Y Hardan; Booil Jo; Thomas W Frazier; Patricia Klaas; Robyn M Busch; Kira A Dies; Rajna Filip-Dhima; Anne V Snow; Charis Eng; Rabi Hanna; Bo Zhang; Mustafa Sahin
Journal:  Contemp Clin Trials Commun       Date:  2021-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.